Skip to main content
OpenTrials

Clinical trial condition

Mucinoses

Explore clinical trials studying Mucinoses. Study availability and eligibility vary by location and protocol.

239 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Mucinoses trial results

Completed

A Treatment Study of Mucopolysaccharidosis Type IIIB

NCT02754076

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +11 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Fundación Cardio Infantil - Instituto de Cardiología Bogotá, Colombia
  • University Medical Center Hamburg Eppendorf, Department of Pediatrics Hamburg, Germany
  • Hospital Clinico Universitario de Santiago Santiago de Compostela, Spain
View Trial Details
Completed

A Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Therapy in Subjects With Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7)

NCT02432144

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +16 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Completed

A Phase 3 Study of UX003 Recombinant Human Betaglucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis Type 7 (MPS 7)

NCT02230566

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Miami Children's Hospital Miami, Florida, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details
Completed

Clinical Evaluation of Acuity 200 (Fluoroxyfocon A) RGP Contact Lens

NCT03971227

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +21 more
Locations
  • Ala Mona Advanced Eye Clinic Honolulu, Hawaii, United States
  • Cornea and Contact Lens Institute of Minnesota Edina, Minnesota, United States
  • Reed Eye Associates Pittsford, New York, United States
View Trial Details
Completed

A Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

NCT02493998

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +13 more
Locations
  • Children's Hospital and Research Center Oakland Oakland, California, United States
  • Melbourne Children's Trials Centre Melbourne, Victoria, Australia
  • Fundacion Cardioinfantil-Instituto de Cardiologia Bogotá, Colombia
  • University Medical Center Hamburg Eppendorf, Department of Pediatrics Hamburg, Germany
View Trial Details

Related conditions